The Discounted Cash Flow (DCF) valuation of Inhibrx Inc (INBX) is 1,108.85 USD. With the latest stock price at 27.18 USD, the upside of Inhibrx Inc based on DCF is 3978.9%.
Based on the latest price of 27.18 USD and our DCF valuation, Inhibrx Inc (INBX) is a buy. buying INBX stocks now will result in a potential gain of 3978.9%.
| Range | Selected | |
| WACC / Discount Rate | 7.7% - 11.0% | 9.3% |
| Long-term Growth Rate | 0.0% - 1.0% | 0.5% |
| Fair Price | 907.30 - 1,441.68 | 1,108.85 |
| Upside | 3237.5% - 5203.2% | 3978.9% |